2Jameson JL. Principle of Moecular Medicinine. Tctowa: Humana Press, 1998 : 1069
3Beggs AH, Koenig M, Boyco FM et al. Detwction of 98% of DMD/ BMD gene deletionsby polymerase chain reaction. HumGenet, 1990, 86 : 45
4杨永青 肖祥熊.放射免疫分析的正常和异常值[M].武汉:同济大学出版社,1998,1..
5Smith - Bindman R, Chu P, Baeehetti Pet al. Prenatal screening for Down syndrome in England and Wales and population -based birth outcomes. Am J Obetet Gymeeol, 2003, 189 (4) : 980
6Seppo H, Markku R, Marko N P. Detection of trlsomy 18 by double screening in a low- risk pregnant population. Fetal Diagn Ther, 1999, 14 (1): 15
7Berm PA, Gainey A, Ingardia CJ et al. Second trimester matermal serum analytes in trlploid pregnancies: correlation with phenotype and sex chromosome complement. Prenat Diagn, 2001, 21 (8) : 680
8Fran?oise Muller.Prenatal biochemical screening for neural tube defects[J].Child’s Nervous System (-).2003(7-8)
9Bryant LD,Green LM.Prenatal screening for Downs syndrome:Some psychosocial implications of a screening for all policy[].Public Health Newison j.2004
10.Trple marker screening for trisomy21,trisomy18and open neural tube defects in singleton pregnancies of native Japanese pregnant women[].The Journal of Obstetrics and Gynaecology Research.2000
3Benn P, Borrell A, Cuckle H, et al. Prenatal detection of down syndrome using massively parallel sequencing (MPS) : a rapid response statement from a committee on behalf of the board of the International society for prenatal diagnosis, 24 October 2011 [J] . Prenat Diagn, 2012, 32 (1): 1-2.
